Cargando…

Multi-omic molecular comparison of primary versus metastatic pancreatic tumours

BACKGROUND: Molecular profiling is increasingly used to match patients with metastatic cancer to targeted therapies, but obtaining a high-quality biopsy specimen from metastatic sites can be difficult. METHODS: Patient samples were received by Perthera to coordinate genomic, proteomic and/or phospho...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brar, Gagandeep, Blais, Edik M., Joseph Bender, R., Brody, Jonathan R., Sohal, Davendra, Madhavan, Subha, Picozzi, Vincent J., Hendifar, Andrew E., Chung, Vincent M., Halverson, David, Mikhail, Sameh, Matrisian, Lynn M., Rahib, Lola, Petricoin, Emanuel, Pishvaian, Michael J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6738081/ https://www.ncbi.nlm.nih.gov/pubmed/31292535 http://dx.doi.org/10.1038/s41416-019-0507-5

Ejemplares similares

A pilot study evaluating concordance between blood-based and patient-matched tumor molecular testing within pancreatic cancer patients participating in the Know Your Tumor (KYT) initiative
por: Pishvaian, Michael J., et al.
Publicado: (2016)

A virtual molecular tumor board to improve efficiency and scalability of delivering precision oncology to physicians and their patients
por: Pishvaian, Michael J, et al.
Publicado: (2019)

Pancreas Cancer‐Associated Weight Loss
por: Hendifar, Andrew E., et al.
Publicado: (2018)

Multiplatform profiling of pancreatic neuroendocrine tumors: Correlative analyses of clinicopathologic factors and identification of co-occurring pathogenic alterations
por: Gong, Jun, et al.
Publicado: (2019)

A step towards personalizing next line therapy for resected pancreatic and related cancer patients: A single institution’s experience
por: Lowder, Cinthya Y., et al.
Publicado: (2020)

Retrospective Case Series Analysis of RAF Family Alterations in Pancreatic Cancer: Real-World Outcomes From Targeted and Standard Therapies
por: Hendifar, Andrew, et al.
Publicado: (2021)

Estimated Projection of US Cancer Incidence and Death to 2040
por: Rahib, Lola, et al.
Publicado: (2021)

Quantification and expert evaluation of evidence for chemopredictive biomarkers to personalize cancer treatment
por: Rao, Shruti, et al.
Publicado: (2016)

Frequency of Appropriate Use of Pancreatic Enzyme Replacement Therapy and Symptomatic Response in Pancreatic Cancer Patients
por: Barkin, Jodie A., et al.
Publicado: (2019)

Challenges in the Integration of Omics and Non-Omics Data
por: López de Maturana, Evangelina, et al.
Publicado: (2019)

Management of Patients With Pancreatic Cancer Using the “Right Track” Model
por: Rosenzweig, Allison, et al.
Publicado: (2023)

Understanding Mucormycoses in the Age of “omics”
por: Soare, Alexandra Y., et al.
Publicado: (2020)

Gemcitabine/nab-paclitaxel with pamrevlumab: a novel drug combination and trial design for the treatment of locally advanced pancreatic cancer
por: Picozzi, Vincent, et al.
Publicado: (2020)

Pharmacogenomic characterization of gemcitabine response – a framework for data integration to enable personalized medicine
por: Harris, Michael, et al.
Publicado: (2014)

Genome-wide multi-omics profiling of colorectal cancer identifies immune determinants strongly associated with relapse
por: Madhavan, Subha, et al.
Publicado: (2013)

Immune checkpoint inhibitors in liver transplant: a case series
por: Rudolph, Mark, et al.
Publicado: (2023)

Comparative Analysis of the Omics Technologies Used to Study Antimonial, Amphotericin B, and Pentamidine Resistance in Leishmania
por: Kaur, Gagandeep, et al.
Publicado: (2014)

Proteomics Discovery of Disease Biomarkers
por: Ahram, Mamoun, et al.
Publicado: (2008)

Extra-pancreatic manifestations reported in association with pancreatitis; an international survey report
por: Dike, Chinenye R., et al.
Publicado: (2023)

Development of an artificial intelligence-derived histologic signature associated with adjuvant gemcitabine treatment outcomes in pancreatic cancer
por: Nimgaonkar, Vivek, et al.
Publicado: (2023)

The role of pembrolizumab in the treatment of PD-L1 expressing gastric and gastroesophageal junction adenocarcinoma
por: Brar, Gagandeep, et al.
Publicado: (2019)

Neoadjuvant treatment of pancreatic adenocarcinoma: a systematic review and meta-analysis of 5520 patients
por: Dhir, Mashaal, et al.
Publicado: (2017)

Integration of Multi-omic Data in a Molecular Tumor Board Reveals EGFR-Associated ALK-Inhibitor Resistance in a Patient With Inflammatory Myofibroblastic Cancer
por: Hunt, Allison L, et al.
Publicado: (2023)

Beyond the genome to tissue proteomics
por: Liotta, Lance A, et al.
Publicado: (2000)

A New Scientific Journal Linked to a Genetic Database: Towards a Novel Publication Modality
por: Patrinos, George P., et al.
Publicado: (2008)

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Peritoneal Metastases: A Summary of Key Clinical Trials
por: Turner, Kevin M., et al.
Publicado: (2022)

Reconciled rat and human metabolic networks for comparative toxicogenomics and biomarker predictions
por: Blais, Edik M., et al.
Publicado: (2017)

Diagnostic and Therapeutic Roles of the “Omics” in Hypoxic–Ischemic Encephalopathy in Neonates
por: Rasineni, Girish Kumar, et al.
Publicado: (2022)

A randomized phase II trial of nab‐paclitaxel and gemcitabine with tarextumab or placebo in patients with untreated metastatic pancreatic cancer
por: Hu, Zishuo Ian, et al.
Publicado: (2019)

A Computational Approach for Prioritizing Selection of Therapies Targeting Drug Resistant Variation in Anaplastic Lymphoma Kinase
por: McCoy, Matthew D., et al.
Publicado: (2018)

Biomarker Amplification by Serum Carrier Protein Binding
por: Mehta, Arpita I., et al.
Publicado: (2003)

Genome-Scale Characterization of Toxicity-Induced Metabolic Alterations in Primary Hepatocytes
por: Rawls, Kristopher D, et al.
Publicado: (2019)

Leveraging patient‐reported outcomes (PROs) in patients with pancreatic cancer: The Pancreatic Cancer Action Network (PanCAN) online patient registry experience
por: Gupta, Arjun, et al.
Publicado: (2021)

Deep belief network-based approach for detecting Alzheimer's disease using the multi-omics data
por: Mahendran, Nivedhitha, et al.
Publicado: (2023)

Next-generation -omics approaches to drive carboxylate production by acidogenic fermentation of food waste: a review
por: Kumar, Reema, et al.
Publicado: (2023)

Genomic and proteomic approaches for studying human cancer: Prospects for true patient-tailored therapy
por: Carr, Kristen M, et al.
Publicado: (2004)

A Thirteen-Gene Expression Signature Predicts Survival of Patients with Pancreatic Cancer and Identifies New Genes of Interest
por: Newhook, Timothy E., et al.
Publicado: (2014)

Differential colitis susceptibility of Th1- and Th2-biased mice: A multi-omics approach
por: Mukhopadhyay, Sohini, et al.
Publicado: (2022)

OMICS Approaches to Assess Dinoflagellate Responses to Chemical Stressors
por: Roussel, Alice, et al.
Publicado: (2023)

Addressing unmet needs for people with cancer cachexia: recommendations from a multistakeholder workshop
por: Garcia, Jose M., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_losb4uu3o7pctndh16ucd306gq